InvestorsHub Logo
Followers 23
Posts 2120
Boards Moderated 0
Alias Born 06/21/2015

Re: None

Friday, 09/22/2017 6:35:13 PM

Friday, September 22, 2017 6:35:13 PM

Post# of 461276
"ANAVEX™ 2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease."

Could the Good Doctor make this statement in a PR if it weren't true?

Don't let the crooks take your shares...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News